Management of Atrial Fibrillation in Patients 75 Years and Older

Annabelle Santos Volgman; Gatha Nair; Radmila Lyubarova; Faisal M. Merchant; Pamela Mason; Anne B. Curtis; Nanette K. Wenger; Neelum T. Aggarwal; James N. Kirkpatrick; Emelia Benjamin

doi:10.1016/j.jacc.2021.10.037

Related publications

Article2019

Frailty and Anticoagulant Therapy in Patients Aged 65 Years or Older with Atrial Fibrillation

Jiapeng Liu, Xin Du, Mengmeng Li, Zhaoxu Jia, Shangxin Lu, Sanshuai Chang, Ribo Tang, Rong Bai, Jianzeng Dong, Professor Gregory Lip, Changsheng Ma

Article2018

P2246Effectiveness and safety of oral anticoagulants in patients aged 90 years or older with atrial fibrillation

Michela Giustozzi, Maria Cristina Vedovati, Melina Verso, Sergio Conti, Paolo Verdecchia, Giulio Bogliari, Lucia Pierpaoli, Giancarlo Agnelli, Cecilia Becattini

Article2019

Patients aged 90 years or older with atrial fibrillation treated with oral anticoagulants: A multicentre observational study

Michela Giustozzi, Maria Cristina Vedovati, Melina Verso, Luca Scrucca, Serenella Conti, Paolo Verdecchia, Giulio Bogliari, Lucia Pierpaoli, Giancarlo Agnelli, Cecilia Becattini

Article2015

Ten years differences in recently onset atrial fibrillation and flutter incidence and management

Roberto Cemin, Massimiliano Manfrin, Massimo Daves, Werner Rauhe, Aldo Maggioni

Article2009

A084 Similar Benefit in Patients Aged q 75 Years Versus < 75 Years with VMP in First-Line MM and Bortezomib in Relapsed MM

Martin Kropff, PG Richardson, Rudolf Schlag, N Khuageva, Meletios A Dimopoulos, Ofer Shpilberg, Rik Schots, MT Petrucci, Rachel Neuwirth, Anthony Boral, Andrew Cakana, K Liu, William Deraedt, H. Van de Velde, Jesús F. San Miguel